Cognitive bias modification for interpretation bias for Obsessive-Compulsive Disorder
This trial will test whether CBM-I is a feasible and acceptable augmentation to treatment as usual for OCD, and will examine preliminary efficacy by examining clinical outcomes associated with CBM-I.
1 Primary · 1 Secondary · Reporting Duration: Time Frame: Weeks 0, 2, 4, and 8
2 Treatment Groups
Cognitive bias modification with treatment as usual
1 of 2
Psychoeducation with treatment as usual
1 of 2
106 Total Participants · 2 Treatment Groups
Primary Treatment: Cognitive bias modification for interpretation bias · Has Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there currently any open enrollments for this clinical experiment?
"According to the clinicaltrials.gov website, this study is looking for participants and has been actively recruiting since its initial posting on March 24th 2022. The details of the trial were most recently updated April 7th 2022." - Anonymous Online Contributor
What is the capacity of this research endeavor?
"Affirmative. Information available on clinicaltrials.gov shows that recruitment for this trial is currently in progress and commenced on March 24th 2022. As of April 7th, the medical study has been looking to enrol 106 volunteers from one location." - Anonymous Online Contributor